For a 72‑year‑old woman with type 2 diabetes, weight 48.7 kg, normal renal function, currently taking insulin glargine (Lantus) 22 units daily, insulin sensitivity factor 50 mg/dL per unit, and carbohydrate‑to‑insulin ratio 7 g per unit, with blood glucose readings of 110 mg/dL at 18:00, 77 mg/dL at 21:00, and 73 mg/dL at 02:00 and 06:00, what should the basal insulin dose, insulin sensitivity factor, and carbohydrate‑to‑insulin ratio be adjusted to?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Reduce Lantus to 18-20 units immediately to prevent recurrent nocturnal hypoglycemia

This patient is experiencing a dangerous pattern of nocturnal and early morning hypoglycemia (77 mg/dL at 21:00,73 mg/dL at 02:00 and 06:00), indicating excessive basal insulin. The current dose of 22 units must be reduced by approximately 10-20% (2-4 units) to prevent severe hypoglycemia, which poses significant risk in this elderly, low-weight patient 1.

Immediate Basal Insulin Adjustment

Reduce Lantus from 22 units to 18-20 units daily based on the following rationale:

  • Current dose of 22 units = 0.45 units/kg (22 ÷ 48.7 kg), which is appropriate for type 2 diabetes 1
  • However, the glucose trend shows progressive decline from evening through morning (110 → 77 → 73 mg/dL), indicating basal insulin is too high
  • Guidelines recommend reducing insulin by 10-20% when hypoglycemia occurs without clear cause 1
  • For elderly patients (≥70 years) with normal renal function, conservative dosing of 0.2-0.3 units/kg is recommended 2, which translates to approximately 10-15 units for this patient
  • Given her current readings, a reduction to 18-20 units (0.37-0.41 units/kg) represents a safer middle ground

Critical Safety Considerations for This Patient

This 72-year-old woman with low body weight (48.7 kg) is at high risk for severe hypoglycemia with potentially catastrophic consequences:

  • Elderly patients are more vulnerable to hypoglycemia-related falls, fractures, and cardiovascular events 1
  • Nocturnal hypoglycemia (73 mg/dL at 02:00) is particularly dangerous as it may go unrecognized and lead to severe events 1
  • The progressive glucose decline pattern (110 → 77 → 73) suggests basal insulin action is excessive overnight

Insulin Sensitivity Factor (ISF) Adjustment

Increase ISF from 50 to 60-70 mg/dL per unit to reduce correction insulin aggressiveness:

  • Current ISF of 50 is relatively aggressive for an elderly, low-weight patient
  • With recurrent hypoglycemia, the correction factor should be made less aggressive (higher number = less insulin per correction)
  • This prevents "stacking" of correction doses that contribute to hypoglycemia

Insulin-to-Carbohydrate Ratio (ICR) Adjustment

Increase ICR from 1:7 to 1:8 or 1:9 (meaning 1 unit per 8-9 grams of carbohydrate):

  • Current ratio of 1:7 may be contributing to postprandial insulin excess
  • At dinner (59g CHO), current dosing would be 8.4 units; new ratio would give 6.6-7.4 units
  • This modest reduction helps prevent late-evening and nocturnal hypoglycemia from prandial insulin tail effect

Titration Algorithm Going Forward

After implementing the above changes, use this structured approach 1, 3:

Monitor fasting glucose for 3-5 days, then adjust:

  • If fasting BG <70 mg/dL: decrease by 2 units (or 10%)
  • If fasting BG 70-100 mg/dL: no change (appropriate range for elderly patient)
  • If fasting BG 100-130 mg/dL: increase by 1 unit
  • If fasting BG >130 mg/dL: increase by 2 units

Target fasting glucose: 100-130 mg/dL for this elderly patient 1, 4. More aggressive targets (<100 mg/dL) increase hypoglycemia risk without proportionate benefit in older adults with established diabetes.

Special Considerations for Age and Weight

Guidelines specifically recommend more conservative insulin dosing in patients ≥70 years 2, 1:

  • Starting doses should be 0.2-0.3 units/kg rather than 0.4-0.5 units/kg used in younger patients
  • This patient's ideal basal insulin dose is likely 10-15 units (0.2-0.3 units/kg × 48.7 kg)
  • The current dose of 22 units exceeds this recommendation, explaining the hypoglycemia pattern

Low body weight (48.7 kg) amplifies insulin sensitivity, requiring lower absolute doses than standard weight-based calculations might suggest.

Common Pitfall to Avoid

Do not ignore borderline hypoglycemia (70-80 mg/dL) in elderly patients. Values of 77 and 73 mg/dL represent significant hypoglycemia risk, particularly overnight when the patient cannot respond 1. The ADA/EASD guidelines emphasize that "downward adjustment is advisable if any hypoglycemia occurs" 1, and this patient has documented values approaching clinical hypoglycemia on multiple occasions.

The pattern of declining glucose from evening through morning (110 → 77 → 73) is a classic sign of basal insulin overdosing 1 and mandates immediate dose reduction to prevent severe nocturnal hypoglycemia.

Related Questions

In a 53‑year‑old, 37‑kg woman with type 2 diabetes, insulin resistance, and a high‑carbohydrate diet, currently using insulin glargine (Lantus) 24 units daily, an insulin‑to‑carbohydrate ratio of 6 g per unit, and an insulin‑sensitivity factor of 25 mg/dL per unit, what should her insulin‑sensitivity factor, insulin‑to‑carbohydrate ratio, and basal insulin dose be adjusted to?
In a 47-year-old, 99-kg patient with type 2 diabetes on insulin glargine (Lantus) 18 U, insulin‑sensitivity factor 25 mg/dL per unit, and insulin‑to‑carbohydrate ratio 1 U per 10 g, who ate 66 g carbohydrate at 5 pm and has blood glucose readings of 231 mg/dL at 8 pm, 240 mg/dL at 9 pm, and 201 mg/dL at 1 am and will be NPO after midnight, what should the basal insulin dose, insulin‑sensitivity factor, and insulin‑to‑carbohydrate ratio be adjusted to?
A patient taking 30 units of insulin glargine (Lantus) at bedtime has fasting glucose around 215 mg/dL; how much should the insulin dose be increased?
What should the basal insulin glargine (Lantus) dose, insulin‑sensitivity factor, and insulin‑to‑carbohydrate ratio be for a 35‑year‑old male, 80 kg, with serum creatinine 1.18 mg/dL (eGFR 87 mL/min/1.73 m²), fasting blood glucose 73 mg/dL while on 32 U nightly Lantus, and current ISF 25 mg/dL per unit and ICR 10 g per unit?
For a 45-year-old Hispanic male weighing 98.4 kg with newly diagnosed type 2 diabetes and normal renal function, currently on 30 U insulin glargine (Lantus) and an insulin-to-carbohydrate ratio of 1 U per 5 g carbohydrate, with post‑meal insulin drip rates of 6, 4, 8, 6 U and overnight fasting drip rates of 2 U each hour, what should the insulin-to-carbohydrate ratio, basal insulin glargine dose, and insulin sensitivity factor be?
In a patient with retrosternal chest pain and an inferior myocardial infarction (ST‑segment elevation in leads II, III, aVF), what is the best first‑line treatment: (A) aspirin, clopidogrel, heparin; (B) aspirin, clopidogrel, thrombolytic therapy; (C) primary percutaneous coronary intervention (PCI); or (D) aspirin (or clopidogrel) and beta‑blockers?
What is the appropriate management of rib fractures in a patient with cirrhosis?
How is typhoid fever diagnosed in a patient?
What are the recommended dosing, contraindications, and monitoring parameters for amlodipine in adult patients?
In a 60-70-year-old man with diabetes mellitus, hypertension, obesity (BMI 31), former smoker, and mild left ventricular hypertrophy, what is the primary risk factor for his difficulty walking short distances?
For a patient presenting with heart‑failure symptoms, an elevated B‑type natriuretic peptide (BNP) and ventricular hypertrophy, what is the most appropriate next step in management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.